Elsevier Launches SciVal Strata to Enhance Research Evaluation

The Tool Enables Institutions to Establish and Profile High-Performance Teams

AMSTERDAM, March 15, 2011 - Elsevier, a leading publisher of scientific, technical and medical
information products and services, today announced the availability of SciVal
Strata (www.info.scival.com/strata). SciVal Strata is a web-based
research performance tool that offers users the flexibility to construct
relevant contextual data to evaluate research teams or individual
researchers, using a range of indicators based on Scopus data. SciVal Strata
can be used by all members of a subscribing institution to demonstrate
research excellence and to secure, allocate and measure return-on-investment
of funding. The tool also improves recruitment, promotion and collaboration
processes.

SciVal Strata allows researchers and decision makers throughout academic
and governmental organizations to evaluate performance and demonstrate the
value of research in ways that are most relevant to their career stage, field
of expertise and topics of interest. Moreover, it enables users to envision
alternate research groups by 'dragging and dropping' any researcher across
the globe into hypothetical teams and gauge expected changes in performance
by benchmarking 'fantasy' groups against existing groups. Developed in
collaboration with research organizations and powered by the breadth of
Scopus, SciVal Strata provides a unique context for decision-making by
visualizing the performance of teams and researchers both inside and outside
of an organization.

"This tool complements current methodologies used by universities and
government agencies by measuring the performance of research teams and
individuals in ways that were not possible before," said Jay Katzen, Managing
Director of Elsevier Academic and Government Products. "SciVal Strata can
help users make more informed research decisions based on relevant benchmarks
and measures, such as citations or document output. This new approach will
empower users to more accurately assess research performance according to
criteria most important to them and help justify funding, hiring decisions
and partner opportunities."

About the Elsevier SciVal(R) Suite

Elsevier's SciVal suite (www.info.scival.com) of services supports
academic and government leadership in evaluating, establishing and executing
research strategies that optimize the performance of existing assets and
maximize investments to enhance near and long-term productivity. SciVal tools
leverage Scopus(R) data, Elsevier's trusted source of bibliometric data, to
offer innovative yet authoritative solutions. Current suite offerings
include: SciVal Spotlight(TM), a strategic tool that generates unique
institutional and country maps of existing and emerging strengths based on an
interdisciplinary perspective of current performance; SciVal Funding(TM), an
online solution that provides targeted recommendations on grants to pursue
based on pre-populated research profiles and historical awards; SciVal
Experts, a semantic technology-based application that enables researchers to
identify and locate sources of expertise at an individual or departmental
level within and across institutions.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet (www.thelancet.com/) and
Cell (www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/), Reaxys (www.reaxys.com/), MD Consult
(www.mdconsult.com/) and Nursing Consult (
www.nursingconsult.com/), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com/) and
MEDai's Pinpoint Review (www.medai.com/), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier
(www.elsevier.com/), employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC (www.reedelsevier.com/), a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).

    Media Contact
    Jen Saunders/Sandra Plasse
    +1-212-752-8338
    jsaunders@psbpr.com
    splasse@psbpr.com

Media Contact: Jen Saunders/Sandra Plasse, +1-212-752-8338, jsaunders at psbpr.com, splasse at psbpr.com